Senna-doc
NDC Package 71309-113-25
Package Information
Senna-doc is take preferably at bedtime or as directed by a doctoradults and children 12 years of age or older - starting dosage: 2 tablets once a day, maximum dosage: 4 tablets twice a day children 6 to under 12 years - starting dosage: 1 tablet once a day, maximum dosage: 2 tablets twice a day children 2 to under 6 years - starting dosage: 1/2 tablet once a day, maximum dosage: 1 tablet twice a day children under 2 years - starting dosage: ask a doctor, maximum dosage: ask a doctor. Marketed by 3014704014, this product is identified by NDC 71309-113 and is authorized under FDA application part334.
Identification & Billing
- RxCUI: 998740 - sennosides 8.6 MG / docusate sodium 50 MG Oral Tablet
- RxCUI: 998740 - docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
- RxCUI: 998740 - DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71309 - 3014704014
- 71309-113 - Senna-doc
- 71309-113-25 - 25 POUCH in 1 BOX / 2 TABLET, COATED in 1 POUCH
- 71309-113 - Senna-doc
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71309-113). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71309-113-25 identifies a specific commercial package of 25 pouch in 1 box / 2 tablet, coated in 1 pouch of Senna-doc, labeled by 3014704014. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by 3014704014 on March 07, 2016. The current certification is valid through December 31, 2021.
How is this 3014704014 product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71309011325. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.